We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ANIP market cap is 1.22B. The company's latest EPS is USD 0.8157 and P/E is 70.88.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 116.55M | 132.39M | 131.65M | 137.43M | 138.04M |
Operating Income | 12.4M | 15.95M | 8.71M | 15.06M | 5.53M |
Net Income | 5.84M | 9.53M | 749k | 17.8M | -2.69M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 206.55M | 208.48M | 216.14M | 316.39M | 486.82M |
Operating Income | 16.35M | -16.02M | -39.79M | -35.28M | 48.4M |
Net Income | 6.09M | -22.55M | -42.79M | -49.52M | 17.15M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 859.34M | 889.91M | 904.42M | 914.52M | 920.75M |
Total Liabilities | 424.87M | 435.2M | 446.82M | 437.71M | 440.14M |
Total Equity | 409.62M | 429.86M | 432.75M | 451.96M | 455.76M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 456.79M | 461.19M | 771.6M | 760.09M | 904.42M |
Total Liabilities | 244M | 265.49M | 412.86M | 421.55M | 446.82M |
Total Equity | 212.79M | 195.7M | 333.89M | 313.69M | 432.75M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 42.05M | 74.22M | 118.96M | 18.27M | 35.68M |
Investing | -9.18M | -13.73M | -18.51M | 8.93M | 4.48M |
Financing | 75.6M | 79.36M | 67.44M | -19.73M | -21.18M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 45.63M | 15.27M | 3.32M | -31.2M | 118.96M |
Investing | -27.55M | -68.32M | -105.48M | -15.74M | -18.51M |
Financing | 1.25M | -1.44M | 194.6M | -5.13M | 67.44M |
Market Cap | 1.22B |
Price to Earnings Ratio | 70.88 |
Price to Sales Ratio | 2.5 |
Price to Cash Ratio | 5.5 |
Price to Book Ratio | 2.66 |
Dividend Yield | - |
Shares Outstanding | 21.03M |
Average Volume (1 week) | 191.58k |
Average Volume (1 Month) | 407.43k |
52 Week Change | 2.54% |
52 Week High | 70.81 |
52 Week Low | 48.14 |
Spread (Intraday) | 44.11 (64.11%) |
Company Name | ANI Pharmaceuticals Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.anipharmaceuticals.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions